Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-25

FDA Approved: JUNEL FE 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for JUNEL FE 28 DAY, a norethindrone acetate/ethinyl estradiol/ferrous fumarate oral contraceptive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUNEL FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for JUNEL FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)